The notices it replaced
- Reissues: PAR-22-141 NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
- 2 steps back: PAR-19-260 NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
- 3 steps back: PAR-16-168 NEI Research Grant for Vision Related Secondary Data Analysis (R21)
- 4 steps back: PAR-13-035 NEI Research Grant for Secondary Analysis (R21)
- 5 steps back: PAR-09-252 NEI Research Grant for Secondary Data Analysis (R21)
- 6 steps back: PAR-06-326 NEI Research Grant for Secondary Data Analysis (R21)
- 7 steps back: PAR-03-019
Who won it before
66 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $17,865,284 in first-year total cost, median $245,154.
Most frequent study sections
- Special Emphasis Panel[ZEY1 VSN (02)]31
- Special Emphasis Panel[ZEY1 VSN (01)]23
- Special Emphasis Panel[ZEY1 VSN (04)]8
- Special Emphasis Panel[ZEY1 VSN (05)]2
- Special Emphasis Panel[ZEY1 VSN (03)]1
Most frequent institutions
- UNIVERSITY OF PENNSYLVANIA7
- JOHNS HOPKINS UNIVERSITY5
- WASHINGTON UNIVERSITY5
- OREGON HEALTH & SCIENCE UNIVERSITY4
- MASSACHUSETTS EYE AND EAR INFIRMARY3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Identifying Clusters of Vision and Eye Health Problems Using Secondary Surveillance Data1R21EY037293-01 · under PAR-22-141 | REIN, DAVID BWITTENBORN, JOHN | NATIONAL OPINION RESEARCH CENTER, IL | $493,642 | ZEY1 |
| 2025 | Large Language Models for Studying Amblyopia Treatment, Adherence, and Outcomes1R21EY037312-01 · under PAR-22-141 | HRIBAR, MICHELLESUMMERS, ALLISON | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $437,959 | ZEY1 |
| 2025 | Implementation of Instrument-Based Vision Screening in Primary Care Pediatric Offices: Enhancing Early Detection of Sight Threatening Disorders within a Children's Hospital System1R21EY035712-01A1 · under PAR-22-141 | HARTMANN, EEUGENIE | CHILDREN'S HOSPITAL MED CTR OF AKRON, OH | $393,175 | ZEY1 |
| 2025 | A generalizable deep learning platform for unifying quantification of experimental autoimmune uveitis1R21EY036199-01A1 · under PAR-22-141 | YOUSEFI, SIAMAK | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $231,000 | ZEY1 |
| 2025 | Diabetic Retinal Neurodegeneration in Youth Onset Diabetes1R21EY036948-01 · under PAR-22-141 | WOLF, RISA MICHELLE | JOHNS HOPKINS UNIVERSITY, MD | $155,000 | ZEY1 |
| 2024 | Developing methods for the use of conjunctival photographs for trachoma monitoring1R21EY036022-01 · under PAR-22-141 | KEENAN, JEREMY DAVID | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $450,874 | ZEY1 |
| 2024 | The Aging Eyes Study: mitochondrial dysfunction as a driver of age-related vision loss1R21EY036435-01 · under PAR-22-141 | ABRAHAM, ALISON GSUN, JING | UNIVERSITY OF COLORADO DENVER, CO | $431,290 | ZEY1 |
| 2024 | Understanding barriers to accessing eye care and their impacts on the prognosis of dry eye disease1R21EY036433-01 · under PAR-22-141 | LIU, SUHSUN | UNIVERSITY OF COLORADO DENVER, CO | $383,000 | ZEY1 |
| 2024 | Domain-adaptive federated learning to develop machine learning models for predicting incident and progression of geographic atrophy1R21EY035271-01A1 · under PAR-22-141 | ALAM, MINHAJ NUR | UNIVERSITY OF NORTH CAROLINA CHARLOTTE, NC | $379,363 | ZEY1 |
| 2024 | Trends in US Rates of Diabetic Retinal Disease1R21EY035707-01 · under PAR-22-141 | VANDERBEEK, BRIAN L. | UNIVERSITY OF PENNSYLVANIA, PA | $243,750 | ZEY1 |
| 2024 | Novel subsampling and analysis of big data using examples from IRIS ® Registry1R21EY035710-01A1 · under PAR-22-141 | WANG, HAIYINGZHANG, QIANG | WILLS EYE HEALTH SYSTEM, PA | $217,449 | ZEY1 |
| 2023 | Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma1R21EY035298-01 · under PAR-22-141 | WANG, MENGYU | SCHEPENS EYE RESEARCH INSTITUTE, MA | $556,962 | ZEY1 |
| 2023 | Surrogate Augmented Deep Predictive Learning for Retinopathy of Prematurity1R21EY034179-01A1 · under PAR-22-141 | CHEN, YONGHE, LIFANGYING, GUI-SHUANG | UNIVERSITY OF PENNSYLVANIA, PA | $482,124 | ZEY1 |
| 2023 | Achieving Model Fairness on Automatic Primary Open-angle Glaucoma Screening1R21EY035296-01 · under PAR-22-141 | PENG, YIFAN | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $466,125 | ZEY1 |
| 2023 | Leveraging CLEERE axial length data to improve myopia treatment1R21EY035270-01 · under PAR-22-141 | JORDAN, LISA A | OHIO STATE UNIVERSITY, OH | $433,125 | ZEY1 |
| 2023 | Objective quantification of vitreous inflammation using optical coherence tomography1R21EY034543-01 · under PAR-19-260 | TSUI, EDMUND | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $249,988 | ZEY1 |
| 2023 | Long-Term Quality of Life in the Ocular Hypertension Treatment Study Cohort1R21EY034188-01A1 · under PAR-22-141 | GAO, FENGGORDON, MAE O | WASHINGTON UNIVERSITY, MO | $246,254 | ZEY1 |
| 2022 | Using Population Contrast Sensitivity Function Data to Develop Tunable Test Procedures1R21EY033553-01 · under PAR-19-260 | BARBOUR, DENNIS LGARDNER, JACOBSEITZ, AARON R | WASHINGTON UNIVERSITY, MO | $261,156 | ZEY1 |
| 2022 | Secondary Data Analysis for Neonates with Retinal OCT Imaging1R21EY034138-01 · under PAR-19-260 | TOTH, CYNTHIA ANNYING, GUI-SHUANG | DUKE UNIVERSITY, NC | $257,350 | ZEY1 |
| 2022 | Secondary Analyses of data from the Infant Aphakia Treatment Study: Patching in Children with Unilateral Congenital Cataracts and Poor Visual Acuity1R21EY032152-01A1 · under PAR-19-260 | CELANO, MARIANNEDREWS-BOTSCH, CAROLYN DAWSONHARTMANN, EEUGENIELAMBERT, SCOTT RNIZAM, AZHAR | GEORGE MASON UNIVERSITY, VA | $226,804 | ZEY1 |
| 2022 | A Second Look at DREAM: Towards a New Paradigm in Meibomian Gland Evaluation Using Artificial Intelligence1R21EY033881-01 · under PAR-19-260 | LIN, MENG CHINGYU, STELLA | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $219,557 | ZEY1 |
| 2022 | Unified group sequential designs for clustered data (eye level) in randomized eye trials1R21EY032951-01A1 · under PAR-19-260 | DIAO, GUOQINGZHANG, QIANG | GEORGE WASHINGTON UNIVERSITY, DC | $210,803 | ZEY1 |
| 2022 | Resubmission: Latent Class Trajectory Analysis in the OHTS Study1R21EY033518-01A1 · under PAR-19-260 | GORDON, MAE OLIU, LEI | WASHINGTON UNIVERSITY, MO | $196,458 | ZEY1 |
| 2021 | Statistical Unsupervised Learning VF for IIHTT & ONTT1R21EY032522-01 · under PAR-19-260 | KUPERSMITH, MARK J | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $331,170 | ZEY1 |
| 2021 | Sociodemographic predictors of healthcare utilization and adverse outcomes in Medicare beneficiaries with glaucoma1R21EY032953-01 · under PAR-19-260 | ZEBARDAST, NAZLEE | MASSACHUSETTS EYE AND EAR INFIRMARY, MA | $287,527 | ZEY1 |
| 2021 | Outcomes of uveitic cataract and uveitic glaucoma surgery1R21EY032592-01 · under PAR-19-260 | GANGAPUTRA, SAPNA S | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $286,084 | ZEY1 |
| 2021 | Structure-Function Relationships in Stargardt Disease.1R21EY032955-01 · under PAR-19-260 | KONG, XIANGRONG | JOHNS HOPKINS UNIVERSITY, MD | $245,625 | ZEY1 |
| 2021 | TRACHOMA SURVEILLANCE AT SCALE: AUTOMATIC DISEASE GRADING OF EYELID PHOTOS1R21EY032567-01 · under PAR-19-260 | DELLA SANTINA, LUCA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $242,250 | ZEY1 |
| 2021 | Molecular determinants of pathogenicity in viral conjunctivitis1R21EY033174-01 · under PAR-19-260 | VAN GELDER, RUSSELL N. | UNIVERSITY OF WASHINGTON, WA | $220,625 | ZEY1 |
| 2021 | Does Ethnic Variation of the Orbit Determine the Prevalence of Horizontal Strabismus?1R21EY031729-01A1 · under PAR-19-260 | VON BARTHELD, CHRISTOPHER S | UNIVERSITY OF NEVADA RENO, NV | $217,357 | ZEY1 |
| 2021 | A Study of Estrogen and Body Mass Index in Fuchs’ Endothelial Corneal Dystrophy1R21EY032544-01 · under PAR-19-260 | MILLEN, AMY ELIZABETH | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $207,506 | ZEY1 |
| 2021 | Focal nerve fiber layer reflectance analysis for glaucoma evaluation1R21EY032146-01 · under PAR-19-260 | TAN, OU | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $192,500 | ZEY1 |
| 2020 | Retinal vessel features as a marker of idiopathic intracranial hypertension treatment response: a secondary analysis of the idiopathic intracranial hypertension treatment trial1R21EY031726-01 · under PAR-19-260 | MOSS, HEATHER ELSPETH | STANFORD UNIVERSITY, CA | $301,263 | ZEY1 |
| 2020 | Gaze scanning by walking people with visual field loss1R21EY031444-01 · under PAR-19-260 | LUO, GANG | SCHEPENS EYE RESEARCH INSTITUTE, MA | $295,500 | ZEY1 |
| 2020 | Robust AI to develop risk models in retinopathy of prematurity using deep learning1R21EY031883-01 · under PAR-19-260 | KALPATHY-CRAMER, JAYASHREERUBIN, DANIEL L | MASSACHUSETTS GENERAL HOSPITAL, MA | $274,883 | ZEY1 |
| 2020 | Secondary Analysis of Data from the Dry Eye Assessment and Management (DREAM) Study1R21EY031338-01 · under PAR-19-260 | YING, GUI-SHUANG | UNIVERSITY OF PENNSYLVANIA, PA | $254,772 | ZEY1 |
| 2020 | Improved Glaucoma Monitoring Using Artificial-Intelligence Enabled Dashboard1R21EY031725-01 · under PAR-19-260 | YOUSEFI, SIAMAK | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $253,379 | ZEY1 |
| 2020 | OCT in the Ocular Hypertension Treatment Study: 20 Year Follow-up1R21EY031125-01 · under PAR-16-168 | ZANGWILL, LINDA M | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $244,838 | ZEY1 |
| 2020 | Improving Quality of Electronic Health Record Ophthalmic Data for Big Data Analytics1R21EY031443-01 · under PAR-19-260 | HRIBAR, MICHELLE | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $231,000 | ZEY1 |
| 2020 | Integrative analysis of bulk and single-cell RNA-seq data from human retina for age-related macular degeneration1R21EY031877-01 · under PAR-19-260 | LI, MINGYAOXIAO, RUI | UNIVERSITY OF PENNSYLVANIA, PA | $221,543 | ZEY1 |
| 2020 | Innovative Analytical Methods for Repeated Measures in the OHTS Study1R21EY031884-01 · under PAR-19-260 | GORDON, MAE OLIU, LEI | WASHINGTON UNIVERSITY, MO | $203,498 | ZEY1 |
| 2020 | Deep-learning-based prediction of AMD and its progression with GWAS and fundus image data1R21EY030488-01A1 · under PAR-19-260 | CHEN, WEIDING, YING | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $188,198 | ZEY1 |
| 2019 | A hybrid artificial intelligence framework for glaucoma monitoring1R21EY030142-01 · under PAR-16-168 | ELZE, TOBIASYOUSEFI, SIAMAK | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $278,421 | ZEY1 |
| 2019 | Identifying Protective and Risk Factors for Non-infectious Uveitis1R21EY029851-01 · under PAR-16-168 | SOBRIN, LUCIA | MASSACHUSETTS EYE AND EAR INFIRMARY, MA | $263,573 | ZEY1 |
| 2019 | Secondary Analysis of Data from G-ROP Study1R21EY029776-01 · under PAR-16-168 | YING, GUI-SHUANG | UNIVERSITY OF PENNSYLVANIA, PA | $263,417 | ZEY1 |
| 2019 | Additional Analyses of the Data from the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) and CATT Follow-up Study (CATT FS)1R21EY028998-01A1 · under PAR-16-168 | YING, GUI-SHUANG | UNIVERSITY OF PENNSYLVANIA, PA | $256,521 | ZEY1 |
| 2019 | Reducing Adeno-Viral Patient Infected Days: Secondary Analyses1R21EY030524-01 · under PAR-16-168 | GORDON, MAE O | WASHINGTON UNIVERSITY, MO | $235,625 | ZEY1 |
| 2019 | Physical Injuries in Patients with Pediatric Eye Diseases1R21EY029655-01 · under PAR-16-168 | PINELES, STACY | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $234,000 | ZEY1 |
| 2019 | Assessing the Interplay of Vision with Cognitive Functioning, Balance, and Falls in Middle-aged Women1R21EY030363-01 · under PAR-16-168 | MOROI, SAYOKO EMUSCH, DAVID C | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $195,000 | ZEY1 |
| 2019 | Leveraging long-term follow-up in the MUST Trial and Follow-up Study: Remission, Ocular outcomes and Quantifying utility in patients with severe uveitis (MUST-ROQ)1R21EY029757-01 · under PAR-16-168 | SUGAR, ELIZABETH ANN | JOHNS HOPKINS UNIVERSITY, MD | $181,243 | ZEY1 |
| 2018 | Infections of specific periodontal microbiota are associated with risk for age-related macular degeneration1R21EY028209-01A1 · under PAR-16-168 | CHIU, CHUNG-JUNG | ADA FORSYTH INSTITUTE, INC., MA | $248,750 | ZEY1 |
| 2018 | Whole-genome Association Analyses of Refractive Error and Myopia in the UK Biobank Study1R21EY027880-01A1 · under PAR-16-168 | WOJCIECHOWSKI, ROBERT J. | JOHNS HOPKINS UNIVERSITY, MD | $245,469 | ZEY1 |
| 2018 | Image analytics prediction of corneal keratoplasty failure1R21EY029498-01 · under PAR-16-168 | BENETZ, BETH ANNWILSON, DAVID LYNN | CASE WESTERN RESERVE UNIVERSITY, OH | $240,000 | ZEY1 |
| 2018 | Glaucoma progression ? Modeling its trajectory and contributing factors: evidence from AGIS and CIGTS1R21EY028997-01 · under PAR-16-168 | MUSCH, DAVID C | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $202,855 | ZEY1 |
| 2017 | Impact of Peripheral Islands in the Visual Field on Functional Ability in Patients with Retinitis Pigmentosa1R21EY027882-01 · under PAR-16-168 | WOODS, RUSSELL LAURENCE | SCHEPENS EYE RESEARCH INSTITUTE, MA | $308,671 | ZEY1 |
| 2017 | Risk factor anaylysis of perioperative visual loss1R21EY027447-01A1 · under PAR-16-168 | ROTH, STEVEN | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $251,918 | ZEY1 |
| 2017 | Incidence of remission and of cataract in ocular inflammatory diseases1R21EY026717-01A1 · under PAR-13-035 | KEMPEN, JOHN H | MASSACHUSETTS EYE AND EAR INFIRMARY, MA | $227,301 | ZEY1 |
| 2017 | Visual Risk Factors for Motor Vehicle Collision Involvement: SHRP21R21EY027817-01 · under PAR-16-168 | MCGWIN, GERALDOWSLEY, CYNTHIA | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $222,750 | ZEY1 |
| 2017 | 3D OCT Angiography for quantitative characterization of diabetic retinopathy1R21EY027879-01 · under PAR-16-168 | KASHANI, AMIR HSHI, YONGGANG | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $206,250 | ZEY1 |
| 2017 | Improve glaucoma diagnosis using retinal surface contour variability measured by OCT1R21EY027007-01A1 · under PAR-16-168 | TAN, OU | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $151,570 | ZEY1 |
| 2015 | The Pediatric Eye Disease Consortium: a Pooled Analysis of Individual-Participant Data from Population-based Studies1R21EY025313-01 · under PAR-13-035 | JIANG, XUEJUAN | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $272,611 | ZEY1 |
| 2015 | Automated Retinal Analysis for Detection of Age Related Macular Degeneration1R21EY024310-01A1 · under PAR-13-035 | BRESSLER, NEIL MICHAELBURLINA, PHILIPPE MARTIN | JOHNS HOPKINS UNIVERSITY, MD | $215,393 | ZEY1 |
| 2015 | Secondary Analysis of the Data from the Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP)1R21EY025686-01 · under PAR-13-035 | YING, GUI-SHUANG | UNIVERSITY OF PENNSYLVANIA, PA | $194,381 | ZEY1 |
| 2015 | Assessing the impact of glaucoma and its treatment on the person1R21EY025719-01 · under PAR-13-035 | MUSCH, DAVID C | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $193,750 | ZEY1 |
| 2014 | Understanding Diabetic Eye Disease in the Underserved Using Health Data Exchange1R21EY024050-01A1 · under PAR-13-035 | FRENCH, DUSTIN D. | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $228,000 | ZEY1 |
| 2014 | Quantitative Image Analysis Techniques for Optic Nerve Disease1R21EY024036-01 · under PAR-13-035 | LANDMAN, BENNETT A. | VANDERBILT UNIVERSITY, TN | $225,089 | ZEY1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.